Inflammation

Resource Center

Research Summaries

Inflammation

FDA Approves First and Only Subcutaneous Option for CIDP

03/16/2018

The US Food and Drug Administration approved the drug after trials showed a lower rate of relapse in chronic inflammatory demyelinating polyneuropathy or withdrawal for any other reason.

03/16/2018

FDA ALERT

FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions

11/08/2015

Anthony Calabro, MA

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

11/08/2015

Research Summaries

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

FDA Roundup

Key FDA Approvals on Novel Treatment Options for Menopausal Hot Flashes, CDI, Opioid Overdoses, and More

06/13/2023

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...

06/13/2023

Conference Coverage

HIV Persistence Reduced After Doubling Antiretroviral Therapy in Patients

04/18/2023

Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...

04/18/2023

Research Summary

Noninvasive Biomarkers Can Be Used For Monitoring and Managing Ulcerative Colitis

03/22/2023

Jessica Ganga

The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.

03/22/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4